Isis Pharmaceuticals and Ionis Pharmaceuticals on Yahoo Finance

Navigating the stock market often involves researching companies through platforms like Yahoo Finance. When searching for “Isis Pharma” on Yahoo Finance, you might encounter a bit of a redirect. This is because Isis Pharmaceuticals, a company focused on RNA-targeted therapeutics, officially changed its name to Ionis Pharmaceuticals (IONS) in December 2015.

The name change was a deliberate decision. The original name, “Isis,” while referencing an Egyptian goddess of health and magic, unfortunately shared a name with a notorious terrorist organization. Recognizing the negative connotations and potential for brand confusion, the company opted for a fresh start with Ionis Pharmaceuticals.

Therefore, when you search for “Isis Pharma” on Yahoo Finance, you’ll likely be redirected to Ionis Pharmaceuticals (IONS). This is the correct ticker symbol and represents the same company. You can then access a wealth of information on Ionis Pharmaceuticals through Yahoo Finance, including:

• Stock Quotes: Real-time or near real-time stock prices, intraday highs and lows, and trading volume.
• Financial Statements: Access to income statements, balance sheets, and cash flow statements, allowing you to analyze the company’s financial health.
• Analyst Ratings: Insights from financial analysts regarding their buy, hold, or sell recommendations and price targets for the stock.
• Company Profile: An overview of Ionis Pharmaceuticals’ business operations, industry, and key personnel.
• News and Press Releases: The latest news articles and press releases related to Ionis Pharmaceuticals, providing updates on drug development, clinical trials, and corporate events.
• Historical Data: Charts and tables illustrating the stock’s performance over various time periods, enabling trend analysis.
• Competitors: A list of Ionis Pharmaceuticals’ main competitors, allowing for comparative analysis.
• SEC Filings: Access to the company’s filings with the Securities and Exchange Commission (SEC), providing detailed information about their business activities and financial performance.

Ionis Pharmaceuticals is a significant player in the field of RNA-targeted therapeutics. They develop drugs that target RNA to treat a variety of diseases, including neurological, cardiometabolic, and rare diseases. Their approach aims to selectively modulate the production of disease-causing proteins.

Before making any investment decisions based on information found on Yahoo Finance or any other source, it’s crucial to conduct thorough research and consider your own financial circumstances and risk tolerance. Information provided on Yahoo Finance is for informational purposes only and should not be considered financial advice. Consider consulting with a qualified financial advisor before investing.

In summary, while the name “Isis Pharma” is historically associated with the company, its current and correct name is Ionis Pharmaceuticals (IONS). Yahoo Finance is a valuable resource for obtaining information about Ionis Pharmaceuticals and other publicly traded companies, but remember to use it as one tool among many in your investment decision-making process.

750×563 isis pharma unfortunate avoid confusion scientific from www.scientificamerican.com

461×320 isis pharma home facebook from www.facebook.com

640×483 avoid unwanted association isis pharma company from www.hindustantimes.com

416×416 isis pharmaceuticals isis from www.forbes.com

570×370 isis pharmaceuticals isis reports earnings beat wall street pit from wallstreetpit.com

955×703 isis pharmaceuticals isis seeking alpha from seekingalpha.com

1024×1024 isis pharmaceuticals reports data isis ptpb rx phase study from diabetesnewsjournal.com

1607×1030 isis pharmaceuticals isis stock higher results pipeline from warriortradingnews.com

850×1133 iasis pharma participation cphi worldwide iasis pharma from iasispharma.com

635×355 isis heres inocom traders blog from www.ino.com

953×516 isis pharmaceuticals compelling long term story nasdaqions from seekingalpha.com

780×439 isis pharma considers change paris attacks from money.cnn.com

1910×1000 isis pharmaceuticals change ionis pharmaceuticals from www.cnbc.com

720×400 heres isis pharmaceuticals stock shed from www.nasdaq.com